"Those with rheumatoid arthritis and other autoimmune diseases also carry a higher risk of cardiovascular disease than those without these conditions, and the addition of GLP-1 therapy to their immunomodulating therapy may prove to be a successful combination." There are some potential risks to consider, the expert noted
The injections are administered subcutaneously, with Wegovy and Zepbound given weekly and Saxenda administered daily, using pre-filled pens similar to insulin delivery devices
Methods This analysis did not require ethical approval, and a protocol was not pre-registered
This is followed by an increase to 0.5 mg once a week
However, a growing body of real-world data suggests that currently available anti-obesity medicines can lead to treatment discontinuation and weight regain
What is a Battery Bus Bar and How is It Different from a Battery Cable